Table 2
Schedule of enrolment, interventions and assessments
| Study period | Screening | Allocation | During examination | PACU | Day 1 | Day 3 | Day 7 |
| Enrolment: | |||||||
| Inclusion criteria | X | ||||||
| Exclusion criteria | X | ||||||
| Informed consent | X | ||||||
| Randomisation | X | ||||||
| Demographic data | X | ||||||
| Physical examination data | X | ||||||
| Interventions: | |||||||
| The intervention group |  | ||||||
| The control group |  | ||||||
| Assessments: | |||||||
| Clinical monitoring | |||||||
| Vital signs (ECG, HR, MAP, SpO2) | X | X | X | ||||
| MOAA/S | X | X | X | ||||
| BIS | X | X | |||||
| Reference BIS | X | ||||||
| Hypoxaemia | X | X | |||||
| Time to ambulation | X | ||||||
| Airway manoeuvres | X | X | |||||
| Rescue sedation | |||||||
| Remimazolam tosilate | X | ||||||
| Propofol | X | ||||||
| Sleep quality (AIS) | X | X | X | X | |||
| Sedation failure | X | ||||||
| Adverse events | X | X | |||||
| Cost of sedatives | X |
AIS, Athens Insomnia Scale; BIS, Bispectral Index; HR, heart rate; MAP, mean arterial blood pressure; MOAA/S, Modified Observer’s Assessment of Alertness and Sedation; PACU, post-anaesthesia care unit; SpO2, pulse oxygen saturation.